Co-emergence of linezolid-resistant Staphylococcus aureus and Enterococcus faecium in a patient with methicillin-resistant S. aureus pneumonic sepsis

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 2, 2011, Pages 232-233

  An, Dongheui ^a   Lee, Mi Young ^a   Jeong, Tae Dong ^a   Sung, Heungsup ^a   Kim, Mi Na ^a   Hong, Sang Bum ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CHLORAMPHENICOL; COTRIMOXAZOLE; LINEZOLID; MEROPENEM; METICILLIN; MINOCYCLINE; RNA 23S; STEROID; TIGECYCLINE; TIMENTIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD CULTURE; CASE REPORT; CROSS RESISTANCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCUS FAECIUM; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NOSE SMEAR; PLEURA FLUID; PRIORITY JOURNAL; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; TREATMENT DURATION;

ACETAMIDES; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; FATAL OUTCOME; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; PNEUMONIA, STAPHYLOCOCCAL; RNA, RIBOSOMAL, 23S; SHOCK, SEPTIC; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 78651424938     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.09.002     Document Type: Letter

References (11)

1. Bae H.G., Sung H., Kim M.N., Lee E.J., Koo Lee S. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea. Scand J Infect Dis 2006, 38:383-386.
2. Besier S., Ludwig A., Zander J., Brade V., Wichelhaus T.A. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother 2008, 52:1570-1572.
3. Bozdogan B., Appelbaum P.C. Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 2004, 23:113-119.
4. Brickner S.J., Barbachyn M.R., Hutchinson D.K., Manninen P.R. Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. J Med Chem 2008, 51:1981-1990.
5. Jones R.N., Fritsche T.R., Sader H.S., Ross J.E. Zyvox annual appraisal of potency and spectrum program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries. Diagn Microbiol Infect Dis 2007, 59:199-209.
6. Kim M.N., Hwang S.H., Pyo Y.J., Mun H.M., Pai C.H. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol 2002, 40:1376-1380.
7. Meka V.G., Pillai S.K., Sakoulas G., Wennersten C., Venkataraman L., DeGirolami P.C., Eliopoulos G.M., Moellering R.C., Gold H.S. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis 2004, 190:311-317.
8. Pai M.P., Rodvold K.A., Schreckenberger P.C., Gonzales R.D., Petrolatti J.M., Quinn J.P. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2002, 35:1269-1272.
9. Peeters M.J., Sarria J.C. Clinical characteristics of linezolid-resistant Staphylococcus aureus infections. Am J Med Sci 2005, 330:102-104.
10. Sakoulas G., Moise-Broder P.A., Schentag J., Forrest A., Moellering R.C., Eliopoulos G.M. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004, 42:2398-2402.
11. Wunderink R.G., Rello J., Cammarata S.K., Croos-Dabrera R.V., Kollef M.H. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003, 124:1789-1797.